Lexicon Pharma (LXRX) Tops Q3 EPS by $1.22, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. META

Go back to Lexicon Pharma (LXRX) Tops Q3 EPS by $1.22, Revenues Beat

Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update

November 7, 2019 7:00 AM EST

THE WOODLANDS, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended September 30, 2019.

We continue to make good progress on our XERMELO business, with XERMELO net sales growing more than 30% in the third quarter of 2019 versus the same period in... More